Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02161068 · ClinicalTrials.gov registry record
Clinical Care of Autosomal Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping
A clinical trial, sponsored by The Rogosin Institute.
- Completed
- Registry status
- 79
- Enrollment target
NCT02161068 is a clinical trial that has completed, run by The Rogosin Institute. The registered enrollment target is 79 participants.
The verdict
NCT02161068 has completed, sponsored by The Rogosin Institute.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
This is a retrospective analysis to include demographic, clinical, biochemical, and genetic data that will further explore the natural history of ADPKD and assess the factors that are likely to be associated with the progression of disease and the incidence of complications including progressive chronic kidney disease, cardiovascular disease, and cerebrovascular disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2013-12 |
| Est. Completion | 2021-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02161068
The ClinicalTrials.gov registry entry for NCT02161068 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Rogosin Institute, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02161068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02161068 about?
NCT02161068 is a clinical study titled "Clinical Care of Autosomal Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping". This is a retrospective analysis to include demographic, clinical, biochemical, and genetic data that will further explore the natural history of ADPKD and assess the factors that are likely to be associated with the progression of disease and the incidence of complications including progressive chr...
What is the current status of trial NCT02161068?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2013-12. Estimated completion is 2021-11-01.
Who is sponsoring clinical trial NCT02161068?
This trial is sponsored by The Rogosin Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.